arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Addus HomeCare Corporation

ADUS Health Care Medical/Nursing Services
$118.76
Today
as of Sep 4, 16:45 ET
Last 30 days -0.39% Jul 28 → Sep 04
$113.07 $115.22 $117.38 $119.53 $121.68 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$117.62
High
$119.49
Low
$117.40
Volume
$175,356
Avg Vol
$215,689
Mkt Cap
$2.2B
P/E (TTM)
28.25
Beta
—
52w High
$124.44
52w Low
$87.95
Div Yield
—
Shares Out
$19M

Recent Press Releases & News last 60 days · 25 items

Aug 28 · 20:12 Simply Wall St.
Is Addus HomeCare (ADUS) Undervalued After Its Q2 Earnings Beat?
Aug 28 · 18:15 Simply Wall St.
Addus HomeCare (ADUS) Stock Looks Cheap Relative To Fair Value
Aug 27 · 17:45 StockStory
Senior Health, Home Health & Hospice Stocks Q2 In Review: Addus HomeCare (NASDAQ:ADUS) Vs Peers
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$88
$124
84% of range
Avg surprise (last 3)
+3.4%
Avg reaction (last 2)
-0.0%
50% positive
Latest IV / EM
29%
EM ±4.5% · $120 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.78$0.96$1.14$1.31$1.49 Actual $0.78Actual $0.91Actual $0.95Actual $0.97Actual $1.10Actual $1.10Actual $1.29Est $1.22Actual $1.31Est $1.33Actual $1.24Actual $1.41Est $1.33Actual $1.49 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$99M$198M$297M$396M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.49 — — — — financials
Mon May 4, 2026Mar/2026 $1.41 $1.33 +6.0% +9.3% +0.6% earnings
Tue Sep 30, 2025Sep 2025 $1.24 — — — — financials
Mon Aug 4, 2025Jun/2025 $1.31 $1.33 -1.5% — — earnings
Mon May 5, 2025Mar/2025 $1.29 $1.22 +5.7% — -0.6% earnings
Mon Sep 30, 2024Sep 2024 $1.10 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.10 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.97 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.95 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.91 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.78 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$377M$364M—$362M$349M$338M—$290M
Cost of revenue$256M$248M—$246M$236M$230M—$198M
Gross profit$122M$116M—$117M$114M$108M—$92M
Operating income$39M$34M—$33M$33M$31M—$26M
Net income$28M$25M—$23M$22M$21M—$20M
EPS (diluted)$1.49$1.36—$1.24$1.20$1.16—$1.10

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$100M$103M$82M$102M$91M$97M$99M$223M
Inventory————————
Total current assets$284M$273M$269M$261M$263M$258M$260M$333M
Total assets$1.46B$1.44B$1.44B$1.42B$1.41B$1.41B$1.41B$1.15B
Long-term debt$62M$91M$121M$151M$169M$199M$218M—
Total liabilities$308M$320M$352M$373M$387M$412M$442M$205M
Total equity$1.15B$1.12B$1.09B$1.05B$1.02B$995M$970M$948M

Implied volatility — last 90 days

22%43%64%85%106% Jun 07 — IV 56% · EM ±7.7%Jun 08 — IV 43% · EM ±5.6%Jun 09 — IV 51% · EM ±6.4%Jun 10 — IV 50% · EM ±5.9%Jun 11 — IV 50% · EM ±5.5%Jun 12 — IV 53% · EM ±5.5%Jun 15 — IV 74% · EM ±5.4%Jun 19 — IV 26% · EM ±5.8%Jun 22 — IV 29% · EM ±6.0%Jun 23 — IV 31% · EM ±6.4%Jun 24 — IV 35% · EM ±7.0%Jun 25 — IV 42% · EM ±8.2%Jun 26 — IV 40% · EM ±7.7%Jun 29 — IV 38% · EM ±6.7%Jun 30 — IV 29% · EM ±5.1%Jul 01 — IV 44% · EM ±7.3%Jul 02 — IV 30% · EM ±4.8%Jul 03 — IV 31% · EM ±4.8%Jul 06 — IV 35% · EM ±4.8%Jul 07 — IV 36% · EM ±4.8%Jul 08 — IV 39% · EM ±4.9%Jul 09 — IV 39% · EM ±4.6%Jul 10 — IV 43% · EM ±4.7%Jul 13 — IV 56% · EM ±4.7%Jul 14 — IV 47% · EM ±3.4%Jul 15 — IV 81% · EM ±4.8%Jul 16 — IV 106% · EM ±4.4%Jul 20 — IV 33% · EM ±7.7%Jul 21 — IV 32% · EM ±7.3%Jul 22 — IV 28% · EM ±6.5%Jul 23 — IV 33% · EM ±7.5%Jul 24 — IV 32% · EM ±7.0%Jul 27 — IV 29% · EM ±6.1%Jul 28 — IV 28% · EM ±5.8%Jul 29 — IV 30% · EM ±6.0%Jul 30 — IV 41% · EM ±8.1%Jul 31 — IV 49% · EM ±9.4%Aug 03 — IV 49% · EM ±8.6%Aug 04 — IV 27% · EM ±4.7%Aug 05 — IV 30% · EM ±5.1%Aug 06 — IV 27% · EM ±4.3%Aug 07 — IV 28% · EM ±4.3%Aug 10 — IV 31% · EM ±4.3%Aug 11 — IV 45% · EM ±5.9%Aug 12 — IV 39% · EM ±4.9%Aug 13 — IV 44% · EM ±5.2%Aug 14 — IV 50% · EM ±5.6%Aug 17 — IV 57% · EM ±4.7%Aug 18 — IV 60% · EM ±4.3%Aug 24 — IV 23% · EM ±4.8%Aug 25 — IV 27% · EM ±5.6%Aug 26 — IV 24% · EM ±4.8%Aug 27 — IV 25% · EM ±4.8%Aug 28 — IV 24% · EM ±4.6%Aug 31 — IV 25% · EM ±4.4%Sep 01 — IV 26% · EM ±4.5%Sep 02 — IV 31% · EM ±5.2%Sep 03 — IV 29% · EM ±4.7%Sep 04 — IV 29% · EM ±4.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in